-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Innoviva, Maintains $35 Price Target

Benzinga·02/26/2026 12:54:07
Listen to the news
BTIG analyst Julian Harrison reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $35 price target.